An immune system digital twin supporting precision medicine is still rather far from prime time; however, existing research may be sufficient to begin developing an initial prototype.
From discovery of a new type of asthma driver to assessing personalized risk with using inhaled corticosteroids, metabolomics research brings new information about severe asthma.
To streamline workflow and reduce cost of testing, researchers at Brown University and Columbia University explore new single-cell analysis (SCA) technology and techniques in fresh and frozen tissues.
One study illuminates the genes that may prove useful in predicting how ulcerative colitis will progress in children and teens; the other investigates poorly understood disease-relevant biological pathways.
Projects at Community Health Systems and other health networks likely will produce evidence that will enhance precision medicine programs.
Rapidly identifying rare genetic conditions has been difficult using traditional testing, according to experts implementing rWGS at a national scale.
Two examples highlighting how decision-making tools are developing from curated genomic data to improve clinical implementation of precision medicine.
Research team identifies five disease cohort categories for which voice changes have been associated with specific diseases with well-recognized unmet needs.
Watching a new set of genes for ALS treatment connections, using remote sleep monitoring for detecting Parkinson’s breathing patterns, plus a major investment.
New microbiome study shows that genes impact what types of bacteria are present in the intestines, creating new implications for neurological and emotional health.
